Cargando…
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS
The prevalence of hypertension is increasing globally, while strategies for prevention and treatment of hypertension remain limited. FG-4592 (Roxadustat) is a potentially novel, orally active small-molecule hypoxia-inducible factor (HIF) stabilizer and is being used clinically to treat chronic kidne...
Autores principales: | Yu, Jing, Wang, Shuqin, Shi, Wei, Zhou, Wei, Niu, Yujia, Huang, Songming, Zhang, Yue, Zhang, Aihua, Jia, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492313/ https://www.ncbi.nlm.nih.gov/pubmed/34403364 http://dx.doi.org/10.1172/jci.insight.133690 |
Ejemplares similares
-
Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway
por: Xu, Bing-Can, et al.
Publicado: (2016) -
Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS
por: Mohd Sabri, Nurul Aiza, et al.
Publicado: (2022) -
Retraction Note: Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway
por: Xu, Bing-Can, et al.
Publicado: (2019) -
Expression of eNOS in kidneys from hypertensive patients
por: Gu, Xin, et al.
Publicado: (2010) -
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
por: Li, Huige, et al.
Publicado: (2009)